FF/UMEC/VI
Sponsors
GlaxoSmithKline, Dr. Grace Parraga
Conditions
AsthmaPulmonary Disease, Chronic Obstructive
Phase 3
Comparative Study of Fluticasone Furoate(FF)/Umeclidinium Bromide (UMEC)/ Vilanterol (VI) Closed Therapy Versus FF/VI Plus UMEC Open Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
CompletedNCT02729051
Start: 2016-06-29End: 2017-05-23Updated: 2019-07-15
Effectiveness of Fluticasone Furoate/ Umeclidinium/ Vilanterol (FF/UMEC/VI) Using the Connected Inhaler System (CIS) as Compared With Fluticasone Proprionate/ Salmeterol (FP/SAL) Plus Tiotropium (TIO) in Inadequately Controlled Asthma
WithdrawnNCT03376932
Start: 2019-01-18End: 2021-02-03Updated: 2019-03-25
Evaluation of Triple Therapy Using Magnetic Resonance Imaging in Asthma
Active, not recruitingNCT04651777
Start: 2022-08-08End: 2025-12-31Updated: 2025-08-29
Efficacy and Safety of Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) in Chinese Participants With Inadequately Controlled Asthma
CompletedNCT04937387
Start: 2021-07-29End: 2024-08-05Updated: 2025-08-11
A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
RecruitingNCT05757102
Start: 2023-04-25End: 2027-01-15Target: 292Updated: 2025-10-07
Phase 4
INTREPID: Investigation of TRELEGY Effectiveness: Usual Practice Design
CompletedNCT03467425
Start: 2018-04-11End: 2019-10-10Updated: 2020-09-07
A Comparative Study Between Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy Versus Tiotropium Monotherapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
CompletedNCT03474081
Start: 2018-03-29End: 2019-07-17Updated: 2021-07-15
A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
CompletedNCT03478696
Start: 2018-06-25End: 2019-03-18Updated: 2020-10-28
A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
CompletedNCT03478683
Start: 2018-06-25End: 2019-03-14Updated: 2020-10-28
A Study to Evaluate the Safety and Efficacy of Fluticasone Furoate (FF)/Umeclidinium(UMEC)/Vilanterol (VI) in Participants With Chronic Obstructive Pulmonary Disease (COPD)
CompletedNCT04923347
Start: 2023-06-06End: 2024-03-14Updated: 2025-03-24
To Evaluate Real-World Effectiveness of Fluticasone Furoate/Umeclidinium Bromide/Vilanterol (FF/UMEC/VI) in a Single Inhaler (Trelegy Ellipta) in Participants With Symptomatic COPD
CompletedNCT05535972
Start: 2022-10-14End: 2023-09-25Updated: 2025-12-11